A Pilot Study Evaluating a Novel Magneto-Fluidic System for Ultra-High Throughput Detection of Circulating Tumor Cells in Patients with Metastatic and Loco-regional Urothelial Bladder Cancer IUSCC-0552
The purpose of this study is to determine if cancer cells in blood can be reliably detected in bladder cancer patients using a new blood test known as a "liquid biopsy."
The purpose of this study is to test and optimize this magneto-fluidic system we have developed to capture circulating tumor cells from samples of patients with advanced urothelial bladder cancer, and potentially applu this system to an earlier clinical stage cohort to predict advanced pathology.
- IRB Number: 1601654610
- Research Study Identifier: TX5848
- Principal Investigator: Hristos Kaimakliotis, MD
Contact the research team to learn more about this study.
Fields marked with asterisk (*) are required